All Articles

The diagnostics firm is launching a monthly webinar series, an unusual move that blends investor relations with direct-to-consumer marketing. Is this the new playbook?

The mREIT just authorized a massive share repurchase, signaling deep confidence. But what does this move reveal about its strategy in a volatile RMBS market?

As traditional chip scaling falters, Qnity Electronics launches a new hub for advanced packaging, a critical 'stacking' technology set to define the future of AI.

Murphy Oil's successful Bubale-1X well off Côte d’Ivoire's coast is a major strategic win in a re-emerging energy hotspot. But can the company navigate the deepwater risks?

Elevar Therapeutics' new trial for lirafugratinib aims for a tumor-agnostic label, a strategic move to redefine cancer treatment beyond a single indication.

With its new Superagent, i10X is challenging the AI industry's 'move fast and break things' ethos, offering a controlled, cost-effective alternative.

Our thirst for AI and fast EV charging has an energy problem. The solution may lie in tiny silicon components delivering a crucial leap in efficiency.

A medical device firm's aviation arm partners with a PGA star. We dissect how Flyte's deal with Emiliano Grillo signals a major disruption in athlete travel.

With a sub-$10M market cap and blockbuster data, IMUNON's CEO faces a critical test: convince Wall Street its ovarian cancer drug is the real deal.

TD SYNNEX adds Douglas Britt, a hyperscale and manufacturing expert, to its board, signaling a strategic move to dominate AI and data center infrastructure.

Beyond the code, AI's future is being forged in steel and concrete. A new class of builders is turning old industrial sites into power-hungry data centers.

With slowing growth but a new AI focus, PagerDuty brings in Eric Prengel, a finance leader with deep investment banking roots, to steer its next chapter.

Beyond the press release, AXT's appointment of China expert Tracy Liu to its board is a calculated move to navigate the AI-driven semiconductor boom and geopolitical risks.

The U.S. Army is betting billions on Palantir and Anduril to build its new digital brain. This isn't just a tech upgrade; it's a radical shift in how the military buys weapons and fights wars.

As billions flow into tax-advantaged passive investments, Passive Realty Group's network expansion signals a larger shift in how wealth is preserved.

After a stunning FDA reversal for its Huntington's drug, uniQure seeks $150M. A look at the high-stakes financing behind a pipeline of hope and risk.

As CFO Matt Bilunas departs months before a new CEO arrives, the move signals a strategic reset. This isn't a crisis; it's a calculated leadership shift.

A major tech vendor is backing a non-profit data standard. Is this the end of data silos in higher ed, or a strategic play in a competitive market?

A sports medicine doctor is launching a NY-based team for TBT's $2M prize, stacking the bench with NBA legends to fund a powerful philanthropic vision.

A 39-year-old Indiana software firm is formalizing its AI practice, promising to end the cycle of failed pilots with a production-first 'studio' model.